Table 3.
Patient characteristics |
Mean ± SD, or n (%) |
Total | 33 |
Age, years | |
Mean ± SD | 62±15.0 |
Range | 23-82 |
Men | 16 (48.4) |
Race | |
Hispanic | 16 (48.4) |
Non-Hispanic white | 7 (21.2) |
Non-Hispanic black | 9 (27.3) |
Asian | 1 (3.0) |
NIH Stroke Score at baseline | |
Median | 5 |
Range | 2-17 |
Time from symptom onset to treatment initiation, h | |
Mean ± SD | 15.7±7.2 |
Range | 1.0-25.1 |
Stroke subtype | |
Cardioembolic | 11 (33.3) |
Lacunar | 15 (45.5) |
Large vessel atherosclerotic | 4 (12.1) |
Other/cryptogenic | 3 (9.1) |
Treatment | |
Completed ≥11 of 12 doses | 30 (90.9) |
Completed ≥9 of 12 doses | 32 (97.0) |
NIH = National Institutes of Health.